FDA Grants Approval for Commercial Manufacturing at Rezon Bio’s Warsaw-Duchnice Production Facility

Strategic Regulatory Milestone for Global Biologics Manufacturing FDA Rezon Bio has announced that its advanced manufacturing facility located in Warsaw‑Duchnice has successfully received approval from the U.S. Food and Drug Administration for the commercial production of a biosimilar therapy, marking…











